On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Björn Dahlöf

ResearcherPublications, citations & collaboration network

Björn Dahlöf is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Björn Dahlöf have?

ScholarIQindexed works

Björn Dahlöf has 131 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Björn Dahlöf have?

ScholarIQcitation count

Björn Dahlöf has 17,632 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Björn Dahlöf?

ScholarIQh-index

Björn Dahlöf has an h-index of 45 in OpenAlex.

What is the i10-index of Björn Dahlöf?

ScholarIQi10-index

Björn Dahlöf has an i10-index of 81 in OpenAlex.

What is the OpenAlex record for Björn Dahlöf?

ScholarIQopenalex

The OpenAlex for Björn Dahlöf is on the source record.

What are the most-cited papers on Björn Dahlöf?

ScholarIQmost cited works
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
Björn Dahlöf, Richard B. Devereux, Sverre E. Kjeldsen, Stevo Julius, Gareth Beevers, Ulf dé Fairé, Frej Fyhrquist, Hans Ibsen, Krister Kristiansson, Ole Lederballe‐Pedersen, Lars Lindholm, Markku S. Nieminen, Per Omvik, Suzanne Oparil, Hans Wedel
The Lancet. 20025,421 Citations
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
Peter Sever, Björn Dahlöf, Neil R Poulter, Hans Wedel, Gareth Beevers, Mark J. Caulfield, Rory Collins, Sverre E. Kjeldsen, Arni Kristinsson, Gordon T. McInnes, Jesper Mehlsen, Markku S. Nieminen, Eoin OʼBrien, Jan Östergren
The Lancet. 20033,792 Citations
Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study
Lennart Hansson, Thomas Hedner, Per Lund‐Johansen, Sverre E. Kjeldsen, Lars Lindholm, Jan Otto Syvertsen, Jan Lanke, Ulf dé Fairé, Björn Dahlöf, Bengt E. Karlberg
The Lancet. 2000902 Citations

Related on ScholarIQ

470M+ articles · free account